nPhase, Inc. builds clinical research technology that unifies clinical trial and real-world data into a single foundation for clinical decision-making. Its enterprise platform nPhase.ai, launched in September 2026, pairs a Unified Data Management System (UDMS) with an AI-native Statistical Computing Environment (SCE) to take pharmaceutical sponsors and CROs from data acquisition through regulatory submission in weeks rather than months. The company grew out of REDCap Cloud, its EDC for small and mid-size sponsors, academic research organizations and MedTech studies, and is headquartered in Atlantic Beach, Florida.
1
Round
1
Industry
5
Tags
Nov 2, 2026
Latest raise
Funding activity · 1 round
Nov 2, 2026
$30M
Series C+
Led by Viking Global Investors
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
